Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Sales | 5,292,800 | 5,047,000 | 5,204,400 | 5,209,500 | 5,150,400 |
| Cost of Goods | 947,400 | 816,400 | 909,300 | 1,155,200 | 1,200,900 |
| Gross Profit | 4,345,400 | 4,230,600 | 4,295,101 | 4,054,300 | 3,949,500 |
| Operating Expenses | 2,749,000 | 2,476,900 | 7,471,600 | 2,630,400 | 2,687,500 |
| Operating Income | 1,596,800 | 1,754,100 | -3,176,200 | 1,424,100 | 1,262,900 |
| Other Income | -129,100 | -70,700 | -161,200 | -1,656,900 | -56,600 |
| Pre-tax Income | 1,467,700 | 1,683,400 | -3,337,400 | -232,800 | 1,206,300 |
| Income Tax | 309,200 | 370,300 | 292,000 | 232,800 | 247,500 |
| Net Income Continuous | 1,158,500 | 1,313,100 | -3,629,400 | -465,600 | 958,800 |
| Net Income | $1,158,500 | $1,313,100 | $-3,629,400 | $-465,600 | $958,800 |
| EPS Basic Total Ops | 1.06 | 1.20 | -3.31 | -0.43 | 0.88 |
| EPS Basic Continuous Ops | 1.06 | 1.20 | -3.32 | -0.43 | 0.88 |
| EPS Diluted Total Ops | 1.06 | 1.20 | -3.31 | -0.43 | 0.88 |
| EPS Diluted Continuous Ops | 1.06 | 1.20 | -3.32 | -0.43 | 0.88 |
| EBITDA(a) | $1,902,800 | $2,060,400 | $-2,895,900 | $1,707,400 | $1,544,400 |